
Keywords: داروهای ضد رماتیسمی اصلاح کننده بیماری; Influenza; Vaccination rate; Predictors; Inflammatory rheumatic disease; CI; Confidence Interval; DMARD; disease-modifying antirheumatic drug; EULAR; The European League against Rheumatism; GP; General Practitioner; HIV; Human Immunodeficiency Virus; IVR;